Navigation Links
Shares Of AVI BioPharma Drops On Reports Of Disappointing Early Drug Trail

Shares of AVI BioPharma Inc. has lost a third of their value on Wednesday after the company reported disappointing clinical trial data for its experimental treatment against the hepatitis C virus. //

The shares of AVI were down $2.43, or 33 percent, to $4.83, in the heavy morning trade on the Nasdaq.

The Portland, Oregon based biotechnology company said that the results came from the second stage of a trial involving the antisense drug, called AVI-4065, among patients infected with the liver-damaging virus. Company officials have said that the drug showed favourable safety in all patients treated so far, but patients have experienced only a mean "slight decrease" in the amount of virus in their bloodstreams both during and after treatment.

In a press release the company officials said that during the 14 days of treatment, three of five patients evaluated had an initial decrease in viral load, whereas two of five exhibited little initial change. They were quick to point out that the results were still only preliminary and in only a small number of patients, and that patients remained enrolled in the study. They stated that the formal results of the trial were expected around the end of the year.

Antisense drugs, like AVI-4065, are artificial pieces of genetic material that are meant to prevent genes from expressing disease-causing proteins. Sadly the technology has not yet achieved great success despite high earlier hopes.


'"/>




Page: 1

Related medicine news :

1. ViroPharma Shares Fall As FDA Moves Towards Generic Vancocin
2. Sun Pharma Allots Shares Upon Fccbs Conversion
3. Zenotech Issues 20 Lakh Shares to Ranbaxy for Rs 20 Cr
4. Female Ratio Drops Alarmingly In Himachal Due To Feticides
5. 1.8 mn Delhi Children to Receive Anti-polio Drops
6. Antibiotic Ear Drops Favored Over Oral Antibiotics for Ear Infections
7. No Smoking During Play Rehearsals: UK’s Health Ministry Drops the Curtain
8. Russia Reports First SARS Case
9. Uganda Reports Failure To Contain Sleeping Sickness
10. Reports of Hantavirus infection in India raise concerns
11. Controversy Surrounding The HIV Positive Reports Of One-Year Girl In Kerala
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Shares AVI BioPharma Drops Reports Disappointing Early Drug Trail

(Date:7/29/2015)... ... July 29, 2015 , ... Ticket Down is a reliable source of authentic ... USA . , The international soccer schedule of matches played on American soil ... September 8th, one of the world’s greatest teams, Brazil, will travel to North America ...
(Date:7/29/2015)... ... July 29, 2015 , ... This year, the threat of flooding is higher ... where there is water, mold is not far behind. Paul Davis, a leading provider ... water and mold damage. Paul Davis is regularly called on to handle these types ...
(Date:7/29/2015)... ... July 29, 2015 , ... San Fernando Valley ... Ultherapy. For a limited time only, patients can get the complete treatment process with ... patients who prefer a non-invasive treatment and have loose or sagging skin. , ...
(Date:7/29/2015)... Los Angeles, CA (PRWEB) , ... July 29, 2015 , ... We are privileged to ... at Keck Medicine of USC as the ninth best ophthalmology hospital in the nation for ... the top 10 American hospitals for ophthalmology. , “It is an honor to be ...
(Date:7/29/2015)... ... ... A June 10, 2015 article from the News-Press, entitled " It's Never Too ... skin cancer screenings from an early age. Skin cancer can strike at any age, ... cancer is rarely fatal; however, if left alone for too long, the fatality rate ...
Breaking Medicine News(10 mins):Health News:Cheap USA vs. Brazil Tickets at Gillette Stadium: Ticket Down Cuts Presale Ticket Prices for Brazil vs. USA Men's National Soccer Team (USMNT) at Gillette Stadium 2Health News:Cheap USA vs. Brazil Tickets at Gillette Stadium: Ticket Down Cuts Presale Ticket Prices for Brazil vs. USA Men's National Soccer Team (USMNT) at Gillette Stadium 3Health News:Paul Davis Offers Tips to Minimize Property Damage and Health Risks This Flood Season 2Health News:Paul Davis Offers Tips to Minimize Property Damage and Health Risks This Flood Season 3Health News:San Fernando Valley Dermatology Office, Castle Dermatology Institute, is Now Offering a Promotional Price on Ultherapy 2Health News:21 Years & Counting: The USC Eye Institute Ranks in the Top 10 Ophthalmology Hospitals in America 2Health News:21 Years & Counting: The USC Eye Institute Ranks in the Top 10 Ophthalmology Hospitals in America 3Health News:Get Checked for Skin Cancer Early and Often 2Health News:Get Checked for Skin Cancer Early and Often 3
... Research Institute have developed a simplified and more effective method ... by clinical pharmacologist Dr. Ross Feldman, showed that more patients ... - when their family doctors used a simplified treatment protocol ... drugs available to treat high blood pressure. While the study,s ...
... -- China Holdings, Inc.,(OTC Bulletin Board: CHHL), ... subsidiaries engage in multiple China-focused business activities,including ... and pharmaceuticals, announced today the Company has ... rights to develop and construct,the 2nd Biomass ...
... NORTHBROOK, Ill., Nov. 5 In 1963, when Karl,Johnson, ... for the National,Institutes of Health instead of taking a ... did he know that his research would lay the ... the,world. With just a quick built laboratory, a few ...
... - Halogen Software Inc., the leading,provider of Web-based ... third quarter of 2007 was the organization,s strongest,to ... category with nearly,50 percent year-over-year revenue growth over ... performance is a high priority for our,organization and ...
... Fla., Nov. 5 JM, a 71 year old ... scale ultrasound,despite a PSA of 7.1. The following year, ... was negative despite adding Color Flow Doppler,Ultrasound. At this ... without a clear path to identify a disease process ...
... ABO-incompatible heart transplantation (heart transplantation among non-compatible ... a year old or younger, researchers reported at ... analysis, based on national data reported to the ... transplanting infant hearts across incompatible blood group is ...
Cached Medicine News:Health News:Changing the way doctors treat high blood pressure 2Health News:China Holdings, Inc. Announces 2nd Biomass Renewable Energy Project (Power Capacity: 50 MW); Total Potential: 100 MW in Biomass Energy Pipeline 2Health News:China Holdings, Inc. Announces 2nd Biomass Renewable Energy Project (Power Capacity: 50 MW); Total Potential: 100 MW in Biomass Energy Pipeline 3Health News:China Holdings, Inc. Announces 2nd Biomass Renewable Energy Project (Power Capacity: 50 MW); Total Potential: 100 MW in Biomass Energy Pipeline 4Health News:China Holdings, Inc. Announces 2nd Biomass Renewable Energy Project (Power Capacity: 50 MW); Total Potential: 100 MW in Biomass Energy Pipeline 5Health News:China Holdings, Inc. Announces 2nd Biomass Renewable Energy Project (Power Capacity: 50 MW); Total Potential: 100 MW in Biomass Energy Pipeline 6Health News:China Holdings, Inc. Announces 2nd Biomass Renewable Energy Project (Power Capacity: 50 MW); Total Potential: 100 MW in Biomass Energy Pipeline 7Health News:China Holdings, Inc. Announces 2nd Biomass Renewable Energy Project (Power Capacity: 50 MW); Total Potential: 100 MW in Biomass Energy Pipeline 8Health News:Training Medical Warriors: Tropical Medicine Specialists Who Ward Off Bioterrorist and Global Health Threats Pass the Torch to the Next Generation 2Health News:Training Medical Warriors: Tropical Medicine Specialists Who Ward Off Bioterrorist and Global Health Threats Pass the Torch to the Next Generation 3Health News:Training Medical Warriors: Tropical Medicine Specialists Who Ward Off Bioterrorist and Global Health Threats Pass the Torch to the Next Generation 4Health News:Halogen Software Achieves Most Successful Quarter in Company History - Includes Record Year-Over-Year Overall and License Revenue 2Health News:Halogen Software Achieves Most Successful Quarter in Company History - Includes Record Year-Over-Year Overall and License Revenue 3Health News:New Prostate Cancer Technology Saving Lives 2Health News:New Prostate Cancer Technology Saving Lives 3Health News:Blood-incompatible infant heart transplants safe, may save more lives 2
(Date:7/29/2015)... , July 29, 2015 Touro College has announced ... CanniCare,s application for one of five media marijuana licenses to ... Dept. of Health (DOH).  If CanniCare ... medicinal cannabis.  "Our college is supportive of ... president of the Touro College System. "There is still a ...
(Date:7/29/2015)... , July 29, 2015  AcelRx Pharmaceuticals, ... company focused on the development and commercialization of ... breakthrough pain, today announced that it will release ... Monday, Aug 3rd, 2015. AcelRx management will host ... Time (1:30 p.m. Pacific Time) on Aug 3rd, ...
(Date:7/29/2015)... 29, 2015   BioLife Solutions , Inc. (NASDAQ: ... of proprietary clinical grade hypothermic storage and ... shipping products for cells and tissues  ("BioLife" or ... 2015 financial results will be released on Thursday, August ... conference call and live webcast at 1:30 p.m. PT ...
Breaking Medicine Technology:Touro College Announces Support for CanniCare's Medical Cannabis License Application 2AcelRx Pharmaceuticals to Hold Business Update and Second Quarter Financial Results Conference Call and Webcast on Monday, Aug. 3rd, 2015. 2AcelRx Pharmaceuticals to Hold Business Update and Second Quarter Financial Results Conference Call and Webcast on Monday, Aug. 3rd, 2015. 3AcelRx Pharmaceuticals to Hold Business Update and Second Quarter Financial Results Conference Call and Webcast on Monday, Aug. 3rd, 2015. 4BioLife Solutions to Report Second Quarter 2015 Financial Results and Provide Business Update on August 6, 2015 2
... -- Mesa Laboratories, Inc. (Nasdaq: MLAB ) today ... quarterly dividend of $.12 per share of common stock, up ... payable December 15, 2010, to shareholders of record on November ... Labs has maintained strong cash positions and has continued to ...
... YORK, Nov. 8, 2010 Reportlinker.com announces that ... its catalogue: http://www.reportlinker.com/p0243809/How-IT-Helps-Solve-Pharmas-RD-Problems-in-silico-Drug-Discovery.html ... pipelines and looming patent expirations, the pain of ... increase the R&D productivity ratio and reduce the ...
Cached Medicine Technology:How IT Helps Solve Pharma's R&D Problems: in silico Drug Discovery 2How IT Helps Solve Pharma's R&D Problems: in silico Drug Discovery 3How IT Helps Solve Pharma's R&D Problems: in silico Drug Discovery 4How IT Helps Solve Pharma's R&D Problems: in silico Drug Discovery 5
... A companion product to the new IM3300 ... 300 Watt Xenon Light Source offers some truly ... Source is simply to understand and easy to ... Linvatec has incorporated a new Stand-By Feature, which ...
Ambion's barrier tips prevent cross-contamination of samples by means of an aerosol filter. They are RNase- and DNase-free and are ideal for handling RNA, PCR applications, and for working with radio...
1000 L, Bulk Recommended for 500 and 1000 L pipettes...
Conducting disposable filter-tips....
Medicine Products: